...

首页> 外文期刊>Annals of Oncology >Induction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradiotherapyn in patients with nasopharyngeal carcinoma: a randomized phase II study conducted by the Hellenic Cooperative Oncology Groupn (HeCOG) with biomarker evaluation

【24h】

Induction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradiotherapyn in patients with nasopharyngeal carcinoma: a randomized phase II study conducted by the Hellenic Cooperative Oncology Groupn (HeCOG) with biomarker evaluation

机译：鼻咽癌患者中的诱导化学疗法，伴随放疗和每周顺铂与同等放化疗相比：由希腊合作肿瘤小组（HeCOG）进行的一项具有生物标志物评估的随机II期研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Annals of Oncology》 |2012年第2期|p.427-435|共9页
作者
T. Ciuleanu;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献

1. Induction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradiotherapy in patients with nasopharyngeal carcinoma: A randomized phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluation [J] . FountzilasG., CiuleanuE., BobosM., Annals of oncology: official journal of the European Society for Medical Oncology . 2012,第2期

机译：鼻咽癌患者中诱导化疗后同时放疗和每周顺铂与同时放化疗：由希腊合作肿瘤小组（HeCOG）进行的一项具有生物标志物评估的随机II期研究
2. 8504 Induction chemotherapy (IC) followed by concomitant chemoradiotherapy (CCRT) versus CCRT alone in patients with locally advanced nasopharyngeal carcinoma (LA-NPC) - a randomized phase II study of the Hellenic Cooperative Oncology Group [J] . G.Fountzilas, E.Ciuleanu, A.Kalogera-Fountzila, European Journal of Cancer Supplements . 2009,第2期

机译：局部晚期鼻咽癌（LA-NPC）患者的8504诱导化疗（IC）继之放化疗（CCRT）与单独CCRT的比较-希腊合作肿瘤小组的一项随机II期研究
3. Final results of a randomized phase III trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with stage IVA and IVB nasopharyngeal carcinoma-Taiwan Cooperative Oncology Group (TCOG) 1303 Study [J] . Hong R. L., Hsiao C. F., Ting L. L., Annals of oncology: official journal of the European Society for Medical Oncology . 2018,第9期

机译：诱导化疗随机化化疗试验的最终结果，然后单独进行同时进行化学疗法，单独同时进行IVA和IVB鼻咽癌癌症 - 台湾合作肿瘤组（TCOG）1303研究
4. Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy: pooled analysis of two Hellenic Cooperative Oncology Group (HeCOG) phase III trials [O] . George Fountzilas, Urania Dafni, Mattheos Bobos, 2013

机译：评价含着蒽环类辅助化疗的乳腺癌患者着丝粒17的获得和HER2 /拓扑异构酶IIα基因的状态及蛋白表达的预后作用：两项希腊合作肿瘤小组（HeCOG）III期临床试验的合并分析

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号